Investing.com - Hutchison China MediTech (NASDAQ:HCM) reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Hutchison China MediTech announced earnings per share of $-0.7 on revenue of $157.4M. Analysts polled by Investing.com anticipated EPS of $-0.3381 on revenue of $90.66M.
Hutchison China MediTech shares are up 3% from the beginning of the year, still down 15.94% from its 52 week high of $43.36 set on July 22. They are under-performing the Dow Jones which is up 14.55% from the start of the year.
Hutchison China MediTech shares gained 8.42% in pre-market trade following the report.
Hutchison China MediTech follows other major sector earnings this month
Hutchison China MediTech's report follows an earnings beat by Castellum ADR on July 15, who reported EPS of $0.6132 on revenue of $165.59M, compared to forecasts EPS of $0.588 on revenue of $165.53M.
Axfood ADR had missed expectations on July 15 with second quarter EPS of $0.2621 on revenue of $1.61B, compared to forecast for EPS of $0.2831 on revenue of $1.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar